The total synthesis of (±)-royleanone (I) has been achieved. 5,7,8-Trimethoxy-1-tetralone (III) was converted into (±)-5,7,8-trimethoxy-1-methyl-2-tetralone (VII) via a dihydronaphthalene derivative (IV). The annelation of VII with methyl vinyl ketone gave a (±)-hexahydro-2-oxophenanthrene derivative (VIII), which was then further converted into (±)-11,12,14-trimethoxy-3-oxopodocarpa-5,8,11,13-tetraene (IX). The hydro-genation of IX over platinum oxide gave two dihydro derivatives, (X) and (XI), in a ratio of ca. 1 : 7, these configurations in the A/B ring juncture were identified as trans and cis respectively. Therefore, IX was subjected to thioketalization, followed by desulfurization, to give (±)-11,12,14-trimethoxypodocarpa-5,8,11,13-tetraene (XV). The hydrogenation of XV over 10% palladium on carbon gave (±)-11,12,14-trimethoxypodocarpa-8,11,13-triene (XII), along with a small amount of its cis isomer (XIII). Finally, XII was converted into a hydroxy-1,4-quinone derivative (XIX), which was then treated with isobutyryl peroxide to give (±)-I, whose IR, UV, and NMR spectra were identical in every respect with those of natural royleanone.
No takes yet. Share an insight, caveat, or question.
Yakudo Tachibana (1975) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: